A gene of the Artemisia annua plant doubles the production of artemisinin. Artemisinin-based combination therapy (ACT) is the standard treatment for malaria worldwide, endorsed by the World Health Organization (WHO). The discovery represents an important step towards reducing artemisinin production costs.

Scientists from the Microelectronics Institute of Barcelona (IMB CNM – CSIC), the Universitat Autònoma de Barcelona (UAB), and the Universitat Politècnica de Catalunya (UPC) have developed an autonomous thermoelectric sensor based on silicon nanotechnology to detect flow changes. It can be applied to the detection of breathing problems.

A nanomedicine developed and patented by the research group Nanomol at the Instituto de Ciencia de Materiales de Barcelona (CSIC), and by the Centro de Ingeniería Genética y Biotecnología in Cuba, will be commercialized by the company Heber Biotec. The agreement will allow the development and commercialization of a nanoformulated protein for the improved treatment of diabetic foot ulcers.

A robust, precise and low-cost sensor allows accurate and quick analysis of urinary pH testing. Developed at the Instituto de Microelectrónica de Barcelona (IMB-CNM) of the CSIC, it will be implemented within the first easy-to-use device, suitable for use by lithiasic patients at home. This device is being developed by the company Devicare and is based on a patent by the Universitat de les Illes Balears.

The Spanish National Research Council (CSIC) and the Fundación General CSIC have launched the program ComFuturo, which supposes an alliance between the CSIC and the companies.

A patent obtained by CSIC, and two spanish universities (UAM and UPV) has been distinguished as a proxime accessit in the the madri+d best patents competition. The development, a peptide that can restore the telomerase function, is a good example of new medical research based on cellular therapies. The scientists, Rosario Perona and her team, are co-working with the company Advanced Medical Projects to transform that protein fragment into a drug.